IU Health Opens FDA-Cleared 3D Printing Studio in Indianapolis

IU Health Launches One of First Hospital-Based, FDA-Cleared 3D Printing Studios at 16 Tech 

INDIANAPOLIS, United States — July 1, 2026 — Indiana University Health has opened a dedicated 3D print studio at the 16 Tech Innovation District in Indianapolis, establishing one of the first hospital-based, FDA-cleared additive manufacturing programs in the United States and signaling deeper clinical adoption of the technology in patient care. 

The facility positions additive manufacturing as a point-of-care capability, enabling clinicians to produce anatomical models and surgical aids directly within the health system's own environment. 

Main Development 

According to the reporting, the studio was moved and expanded from its earlier location into the 16 Tech Innovation District, growing a program that began with a single operator and two printers. 

The program is described as one of the first hospital-based initiatives in the nation to hold FDA clearance for its 3D printing operations, allowing produced models to support surgical planning. 

Reported clinical applications include producing patient-specific anatomical replicas, such as flexible models of a patient's heart, intended to help physicians rehearse and shorten complex procedures. 

The move reflects a broader shift in the additive manufacturing sector from prototyping toward regulated, production-grade clinical use. 

Key Highlights: 

• Indiana University Health opened a dedicated 3D print studio at the 16 Tech Innovation District in Indianapolis. 

• The program is among the first hospital-based, FDA-cleared 3D printing operations in the United States. 

• The studio grew from an in-hospital operation with one operator and two printers to an expanded innovation-district facility. 

• Applications include patient-specific anatomical models to support surgical planning and improve outcomes. 

Analyst Insight: 

NMSC analysts note that the migration of additive manufacturing into FDA-cleared, hospital-based settings marks a maturation of the technology from prototyping toward regulated clinical production, potentially expanding demand for medical-grade printers, biocompatible materials, and validated workflow software across healthcare systems. 

Industry Outlook: 

As more health systems pursue in-house, regulatory-cleared 3D printing capabilities, additive manufacturing is likely to see steady clinical adoption in surgical planning and patient-specific modeling, reinforcing its role as an operational tool within regulated medical environments rather than a purely experimental technology. 

Source: VoxelMatters 

For More Information – Download FREE Sample on Additive Manufacturing Market Report

Prepared By: Sanyukta Deb